logo

For the Inventor, By the Inventor

Copenhagen, Denmark

Rigshospitalet


USPTO Granted Patents = 19

% Expired Patents = 47.4


Forward Citations = 36

Loading Chart...
Loading Chart...

54 inventors (with patents filed for the assignee):

goldMedal Ib Jarle Christensen (5 out of 5 patents)

silverMedal Hans Jørgen Nielsen (4 out of 4 patents)

bronzeMedal Nils Aage Brünner (3 out of 5 patents)

4.  Pär Ingemar Johansson (3 out of 5 patents)

5.  Andreas Kjær (3 out of 4 patents)

6.  Mads Nikolaj Holten-Andersen (3 out of 3 patents)

7.  Andreas Kjaer (2 out of 10 patents)

8.  Peter Garred (2 out of 8 patents)

9.  Christoffer Nielsen (2 out of 2 patents)

10.  Niels Behrendt (2 out of 2 patents)

11.  Lars Henning Engelholm (2 out of 2 patents)

12.  Stig Bojesen (2 out of 2 patents)

13.  Børge Grønne Nordestgaard (2 out of 2 patents)

14.  Ross W Stephens (2 out of 2 patents)

15.  Julia S Johansen (2 out of 8 patents)


19 patents:

1. 12673926 - Tetrazine compounds for in vivo imaging (2026-07-07),
2. 12521454 - Ga- andCu-NODAGA-E[c(RGDyK)]for use as PET tracers in the imaging of angiogenesis in humans (2026-01-13),
3. 12433916 - Cell bank of high concentration adipose-derived stem cell composition and related methods (2025-10-07),
4. 12226495 - F-labeled novel tetrazines imaging probes for pretargeting in PET imaging (2025-02-18),
5. 11819552 - Antibody-drug conjugates targeting uPARAP (2023-11-21),
6. 11554261 - System for electrical stimulation during functional MRI (2023-01-17),
7. 10940213 - Antibody-drug conjugates targeting uPARAP (2021-03-09),
8. 10111969 - uPAR targeting peptide for use in peroperative optical imaging of invasive cancer (2018-10-30),
9. 9573984 - Chimeric inhibitor molecules of complement activation (2017-02-21),
10. 9433589 - Injectable pharmaceutical compositions comprising adrenaline and citric acid (2016-09-06),
11. 9381243 - Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof (2016-07-05),
12. 9381166 - Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on alfa-adrenergic and/or beta-adrenergic receptors of the sympathetic nervous system, related to improved clot strength (2016-07-05),
13. 9012154 - Ficolin-3 assay (2015-04-21),
14. 8920775 - Loading technique for preparing radionuclide containing nanoparticles (2014-12-30),
15. 8697384 - YKL-40 as a general marker for non-specific disease (2014-04-15),
Rigshospitalet, located in Copenhagen, Denmark, is a leading university hospital renowned for its advanced medical research and specialized healthcare services. It focuses on a wide range of medical fields, including oncology, cardiology, and neurology, and is dedicated to integrating cutting-edge technology into patient care. The hospital plays a pivotal role in clinical trials and innovative treatment methodologies, contributing significantly to the advancement of medical science and improving patient outcomes both locally and internationally.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Rigshospitalet
19 Patents

#21 in Copenhagen

#152 in Denmark

#32,623 in the World

Copenhagen, DK
Copenhagen, Denmark

Rigshospitalet

Forward Citations = 36

54 inventors:

goldMedal Ib Jarle Christensen (5 out of 5 patents)

silverMedal Hans Jørgen Nielsen (4 out of 4 patents)

bronzeMedal Nils Aage Brünner (3 out of 5 patents)

4.  Pär Ingemar Johansson (3 out of 5 patents)

5.  Andreas Kjær (3 out of 4 patents)

Please report any incorrect information to [email protected]
Loading…